Atara Biotherapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Atara Biotherapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2013 to Q2 2024.
  • Atara Biotherapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 4.9M shares, a 95.1% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 4.9M -96.2M -95.1% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 120M +23.8M +24.6% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 4.26M -91.7M -95.6% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 102M +7.04M +7.42% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 101M +6.75M +7.15% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 96.5M +3.13M +3.35% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 95.9M +4.26M +4.64% Dec 31, 2022 10-K 2024-03-28
Q3 2022 94.9M +6.49M +7.35% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 94.4M +9.6M +11.3% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 93.4M +9.33M +11.1% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 91.7M +8.3M +9.95% Dec 31, 2021 10-K 2023-02-08
Q3 2021 88.4M +11.2M +14.5% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 84.8M +10.4M +14.1% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 84.1M +25.1M +42.6% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 83.4M +26.6M +46.8% Dec 31, 2020 10-K 2022-02-28
Q3 2020 77.2M +23.1M +42.7% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 74.3M +27.4M +58.5% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 58.9M +12.6M +27.3% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 56.8M +10.9M +23.6% Dec 31, 2019 10-K 2021-03-01
Q3 2019 54.1M +8.48M +18.6% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 46.9M +1.55M +3.42% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 46.3M +2.41M +5.5% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 46M +15.2M +49.5% Dec 31, 2018 10-K 2020-02-27
Q3 2018 45.6M +45.6M Sep 30, 2018 10-Q 2018-11-06
Q2 2018 45.3M +45.3M Jun 30, 2018 10-Q 2018-08-01
Q1 2018 43.9M +43.9M Mar 31, 2018 10-Q 2018-05-08
Q4 2017 30.7M +1.8M +6.21% Dec 31, 2017 10-K 2019-02-26
Q3 2017 30.6K* -28.8M Sep 30, 2017 10-Q 2017-11-09
Q2 2017 29.9K* -28.7M Jun 30, 2017 10-Q 2017-08-07
Q1 2017 29.1K* -28.6M Mar 31, 2017 10-Q 2017-05-04
Q4 2016 28.9M +474K +1.67% Dec 31, 2016 10-K 2018-02-27
Q3 2016 28.8M +516K +1.82% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 28.7M +4.55M +18.9% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 28.6M +4.67M +19.5% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 28.5M +8.77M +44.5% Dec 31, 2015 10-K 2017-03-09
Q3 2015 28.3M +26.8M +1776% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 24.2M Jun 30, 2015 10-Q 2015-08-07
Q1 2015 23.9M Mar 31, 2015 10-Q 2015-05-11
Q4 2014 19.7M +7.69M +64.1% Dec 31, 2014 10-K 2016-03-04
Q3 2014 1.51M Sep 30, 2014 10-Q 2014-11-12
Q4 2013 12M Dec 31, 2013 10-K 2015-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.